KIDSWELL BIO CORPORATION revenue breakdown overview

KIDSWELL BIO CORPORATION revenue for the last year amounted to 2.43 B JPY, the most of which — 2.43 B JPY — came from its highest performing source at the moment, Biosimilars, the year earlier bringing 2.57 B JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought KIDSWELL BIO CORPORATION 2.43 B JPY, and the year before that — 2.78 B JPY.